Intellia Therapeutics, Inc. - Common Stock (NTLA)

CUSIP: 45826J105

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Common Stock
Shares outstanding
116,932,531
Total 13F shares
17,671,668
Share change
+704,888
Total reported value
$439,163,056
Put/Call ratio
217%
Price per share
$24.85
Number of holders
84
Value change
+$20,668,372
Number of buys
44
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 45826J105?
CUSIP 45826J105 identifies NTLA - Intellia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NTLA - Intellia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Atlas Venture Associates IX, LLC
13F
Company
3.2%
3,729,788
$59,677,000 30 Jun 2017
13F
FMR LLC
13F
Company
2.8%
3,226,832
$51,630,000 30 Jun 2017
13F
ORBIMED ADVISORS LLC
13F
Company
2.3%
2,662,180
$42,595,000 30 Jun 2017
13F
BlackRock Finance, Inc.
13F
Company
1.4%
1,675,336
$26,806,000 30 Jun 2017
13F
BAKER BROS. ADVISORS LP
13F
Company
0.91%
1,062,120
$16,994,000 30 Jun 2017
13F
VANGUARD GROUP INC
13F
Company
0.85%
997,288
$15,957,000 30 Jun 2017
13F
Temasek Holdings (Private) Ltd
13F
Company
0.68%
790,527
$12,648,000 30 Jun 2017
13F
Granahan Investment Management, LLC
13F
Company
0.23%
267,360
$4,278,000 30 Jun 2017
13F
Artal Group S.A.
13F
Company
0.21%
250,000
$4,000,000 30 Jun 2017
13F
MORGAN STANLEY
13F
Company
0.21%
245,409
$3,926,000 30 Jun 2017
13F
ARK Investment Management LLC
13F
Company
0.15%
174,810
$2,797,000 30 Jun 2017
13F
STATE STREET CORP
13F
Company
0.14%
164,798
$2,638,000 30 Jun 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.08%
93,603
$1,497,000 30 Jun 2017
13F
UNITED SERVICES AUTOMOBILE ASSOCIATION
13F
Company
0.08%
92,700
$1,483,000 30 Jun 2017
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.06%
74,230
$1,188,000 30 Jun 2017
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.06%
70,753
$1,132,000 30 Jun 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.06%
69,349
$1,110,000 30 Jun 2017
13F
UBS Group AG
13F
Company
0.05%
62,304
$997,000 30 Jun 2017
13F
SABBY MANAGEMENT, LLC
13F
Company
0.05%
60,000
$960,000 30 Jun 2017
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.05%
56,700
$907,000 30 Jun 2017
13F
Bank of New York Mellon Corp
13F
Company
0.05%
54,802
$876,000 30 Jun 2017
13F
Neuberger Berman Group LLC
13F
Company
0.04%
49,517
$792,000 30 Jun 2017
13F
PAULSON & CO. INC.
13F
Company
0.04%
48,600
$778,000 30 Jun 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.04%
48,566
$777,000 30 Jun 2017
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.04%
43,409
$695,000 30 Jun 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.04%
42,674
$683,000 30 Jun 2017
13F
NORTHERN TRUST CORP
13F
Company
0.03%
36,596
$585,000 30 Jun 2017
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.03%
36,423
$583,000 30 Jun 2017
13F
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.
13F
Company
0.03%
35,867
$574,000 30 Jun 2017
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.03%
30,400
$486,000 30 Jun 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.03%
30,210
$483,000 30 Jun 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.02%
28,672
$459,000 30 Jun 2017
13F
Airain ltd
13F
Company
0.02%
28,077
$449,000 30 Jun 2017
13F
Tekla Capital Management LLC
13F
Company
0.02%
28,000
$448,000 30 Jun 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.02%
26,966
$430,000 30 Jun 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.02%
26,070
$417,000 30 Jun 2017
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
25,303
$405,000 30 Jun 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.02%
25,143
$402,000 30 Jun 2017
13F
Swiss National Bank
13F
Company
0.02%
20,700
$331,000 30 Jun 2017
13F
ProShare Advisors LLC
13F
Company
0.02%
19,746
$316,000 30 Jun 2017
13F
ELLINGTON MANAGEMENT GROUP LLC
13F
Company
0.02%
19,200
$307,000 30 Jun 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.02%
19,200
$307,000 30 Jun 2017
13F
Alberta Investment Management Corp
13F
Company
0.02%
18,600
$298,000 30 Jun 2017
13F
RHUMBLINE ADVISERS
13F
Company
0.01%
17,166
$275,000 30 Jun 2017
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.01%
15,100
$242,000 30 Jun 2017
13F
GROUP ONE TRADING LLC
13F
Company
0.01%
13,372
$214,000 30 Jun 2017
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.01%
13,224
$212,000 30 Jun 2017
13F
Virtu KCG Holdings LLC
13F
Company
0.01%
12,697
$203,000 30 Jun 2017
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.01%
12,503
$200,000 30 Jun 2017
13F
M&T BANK CORP
13F
Company
0.01%
11,516
$184,000 30 Jun 2017
13F

Institutional Holders of Intellia Therapeutics, Inc. - Common Stock (NTLA) as of Q3 2017

As of 30 Sep 2017, Intellia Therapeutics, Inc. - Common Stock (NTLA) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,671,668 shares. The largest 10 holders included Atlas Venture Associates IX, LLC, FMR LLC, ORBIMED ADVISORS LLC, BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Temasek Holdings (Private) Ltd, Global Thematic Partners, LLC, Ark Investment Management LLC, and GMT CAPITAL CORP. This page lists 84 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders
81
Q3 2017 holders
84
Holder diff
3
Investor Q2 2017 Shares Q3 2017 Shares Share Diff Share Chg % Q2 2017 Value $ Q3 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .